Pre-Seed

Daya Ventures

Based in Sweden and launched by Malin Frithiofsson, Daya is the world’s first Femtech Venture Studio dedicated to closing the gender health gap. It starts where the system fails women, co-creating with patients, clinicians, and researchers to uncover unmet emotional, clinical, and systemic needs in women’s health. From these insights, Daya builds and scales startups that deliver meaningful, evidence-based solutions across the full spectrum of care. By combining deep sector expertise with a collaborative, design-led approach, it transforms overlooked problems in women’s health into high-impact, scalable ventures.

Series A and Late-Stage

Nuttall Women's Health 

Nuttall Women’s Health invests in early- to growth-stage life science and biotech companies advancing innovation in women’s health. The focus is on ventures building therapeutics, diagnostics, devices, and enabling platforms grounded in validated science and a clear understanding of female biology. By backing companies with strong clinical pathways and scalable solutions, Nuttall Women’s Health helps accelerate breakthroughs that address critical unmet needs across the full spectrum of women’s health. Investment returns are reinvested directly into the mission, creating a virtuous cycle that fuels further research, discovery, and impact in the field.

Venture Capital

FemHealth Ventures

FemHealth Ventures is a venture capital firm dedicated to transforming women’s health by investing in scalable, science-driven solutions across therapeutics, medical devices, diagnostics, and digital health that address critical unmet needs across the full spectrum of care, from reproductive and metabolic health to cardiovascular and neurological conditions. It operates through a distinct FemHealth Framework that defines women’s health as conditions that appear only in women, mostly in women, or differently in women - unlocking a broader, more precise lens for innovation and investment